Navigation Links
New Cancer Treatment Shrinks Pancreatic Tumor
Date:11/23/2008

NASHVILLE, Tenn., Nov. 24 /PRNewswire/ -- A new cancer treatment is realizing outstanding results against pancreatic cancer. Following five weeks of treatment, a patient's large, stage 4 tumor was reduced in size by 70%. After seven more weeks of treatment, it no longer could be definitely identified on scans. Pancreatic cancer usually is fatal six to nine months after diagnosis. NeoPlas Innovation's combination of FDA-approved drugs appears to improve those odds for some patients, based on this result and similar ones seen before the protocol's public availability.

The tumor reduction correlated with resolution of the patient's symptoms of pain and digestive problems. "The cancer isn't gone," emphasized NeoPlas Innovation Director of Research Dr. Stephen B. Cantrell. "There are still several metastatic lesions to address, but this kind of response is virtually unheard of in pancreatic cancer. At the very least, we're looking at his having many, many months of added survival with a quality of life he can truly enjoy."

The patient's daughter discussed her father's treatment, saying "He began the NeoPlas treatment after he became too ill to complete his final course of radiation following chemotherapy." She added, "Since then, he has been able to resume work two to three hours a day, go to lunch with other men and even take a ten-day trip to Europe with my brother."

The cholesterol drug Lovastatin is a key part of this treatment that has arrested or eradicated tumors in 78% of initial patients. The first person treated with the investigative protocol in 2000 had stage 4 melanoma; he remains disease-free today.

Based on experience and relevant lab research to date, staff members expect the best results for several malignancies. In addition to pancreatic cancer and melanoma, they include colon cancer, renal (kidney) cancer, mesothelioma, and a group of sarcomas, including osteosarcoma, cho
'/>"/>

SOURCE NeoPlas Innovation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
2. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
3. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
4. PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
5. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
6. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
7. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
8. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
9. InteRNA Technologies and VU University Medical Center to Develop microRNA-Based Diagnostics and Therapeutics for Cancer
10. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
11. NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...NGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall/-...),aleadinginnovatorandprovideroflessinvasive,minia...ngthetreatmentofadvancedheartfailure,todayannounce...e21stAnnualPiperJaffrayHealthCareConferenceat8:00a...gheldattheNewYorkPalaceHotel,December1-2. ,, Al...
(Date:11/24/2009)...SDA,Md.,Nov.24/PRNewswire-Asia/--ChindexInternatio...ndentAmericanproviderofWestern,healthcareproductsa...ncedthattheCompanywillattendthe21stAnnualPiperJaff...er1-2,2009,atthe,NewYorkPalaceHotel. , Manage...day,December1,2009,andholdone-on-onemeetingsthrou...
(Date:11/24/2009)...E,Calif.,Nov.24/PRNewswire-FirstCall/--Endologix,I...atmentsforaorticdisorders,announcedtodaythatithasf...epatentinfringementlawsuitbroughtagainstitinOctobe...DistrictCourtinIndianapolis,Indiana. ,, Endolog...tedStatesPatentandTrademarkOffice(USPTO)conductspr...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Sysmex America Debuts High end Sample Management System During AACC 52129 1Sysmex America Debuts High end Sample Management System During AACC 52129 2Sysmex America Debuts High end Sample Management System During AACC 52129 3Understanding Managed Markets 3A Effective Market Research Structures 26 Activities to Maximize Payer Access 26 Insights 13093 1Understanding Managed Markets 3A Effective Market Research Structures 26 Activities to Maximize Payer Access 26 Insights 13093 2Internet May Be Newest Venue for Teen Tobacco Exposure 52122 1Internet May Be Newest Venue for Teen Tobacco Exposure 52122 2Internet May Be Newest Venue for Teen Tobacco Exposure 52122 3
...a,privately-owned biotechnology company, today ann... financing with the D.E. Shaw Group., The proceed...e,development of its lead compound, nitazoxanide, ...next-generation thiazolide drug candidates for,the...seases. Romark is,currently conducting a U.S. Phas...
...he,publication of important new research results i...ny,s proprietary compounds. FASgen is a leader in,... fatty acid synthase,(FASi), and has conducted ext...isorders, specifically for the treatment of obesit...standing cooperation with The Johns,Hopkins Univer...
Other Medicine Technology:FASgen Announces a New Discovery in Obesity Research 2
(Date:11/26/2009)...ntal (RTDental), a leading dental group practice i...nsion of its services to include LUMINEERS by a ce..., Durham, NC (PRWEB) -- Re... Dr. Doug Macmillan, an experienced LUMINEERS De...raining seminar. RTDental’s ability to fulf...
(Date:11/26/2009)....A. is offering free nationwide confidential consu... pills who have suffered a Deep Vein Thrombosis (D...ther related cardiac issues or had their Gallbladd...6405 or go to the firm’s website at http://...uation form. , (PRWEB) No...
(Date:11/25/2009)...BartleHallConventionCenterwilltemporarilybecomethe...ityhoststhelatestinaseriesofmassivefreeclinicsforu...tentialtobethebiggestoneyet,becauseitwillextendove...ofoveraweekend,"SheriWood,executivedirectoroftheKa...ssociationofFreeClinics(NAFC). ,, Atpreviousone...
(Date:11/25/2009)...entinelleMedicalInc.,aleadingmanufacturerofMagneti...ientificInc.,aleadingproviderofsoftwareenablingtec...st4DAdvancedVisualizationsoftware. ,, Thisinnov...ntbasedmedicalimagingofferinginthemarket.CalgarySc...ntaccess-requiringnosoftwaredownload,andrunsonanyM...
(Date:11/25/2009)...hanksgivingmealswillbedeliveredtoapproximately1,00...FaithInAction/VolunteerActionforAging,aprogramoper...hPlan.Formorethan17yearstheseorganizationshavegath...ealstoseniorsinneedinLongBeach,Lakewood,SignalHill..., "Ourwarmholidaymealsaredeliveredtopeoplewhohave...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...porosis from loss of bone mass, there may be good ...hat it can help improve bone mass in women who suf...se is one of the principal recommendations for pre... An experimental device may help solve this proble...
...nk between air pollution and heart attacks. A...s looks specifically at airborne particulate matte...including coal and also from forest fires, reports...ular and respiratory illnesses, and more specifica...
...th problem in Asia that is getting more serious ev...50), one out of every two fractures in the world w...ted above, it would be sensible for men and women ...e and break easily, is one of the world's most dev...
...er issue of Archives of Internal Medicine, poor he...alth and mental conditions//. Besides basic r... and understand numerical information such as that...te. Researchers from Northwestern University,...
...ice the risk of developing breast cancer, says a n...ined the relation between handedness// and inciden... aged women born between 1932 and 1941, reports sc...breast cancer, and reproductive history. They...
...hool is presenting a paper at the 109th Annual Mee...ngology being held September 25-28, 2005 on the im...dy had involved 514 adult patients with inflammato...sis, recurrent acute rhinosinusitis, barosinusitis...
Other Medicine News:Health News:Beauty Queens Urge On The Importance Of Maintaining Bone Integrity 2Health News:Age Can Changes Symptoms Of Sinusitis 2
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: